High affinity CD16 polymorphism associated with reduced risk of severe COVID-19

• DOI: 10.1172/jci.insight.191314
• Publication Date: 2025-05-22T16:00:32Z
• Authors: Anita E. Qualls; Tasha Tsao; Irene Lui; Shion A. Lim; Yapeng Su; Ernie Chen; Dylan Duchen; Holden T. Maecker; Seunghee Kim-Schulze; Ruth R. Montgomery; Florian Krammer; Charles R. Langelier; Ofer Levy; Lindsey R. Baden; Esther Melamed; Lauren I.R. Ehrlich; Grace A. McComsey; Rafick P. Sekaly; Charles B. Cairns; Elias K. Haddad; Albert C. Shaw; David A. Hafler; David B. Corry; Farrah Kheradmand; Mark A. Atkinson; Scott C. Brakenridge; Nelson I. Agudelo...; Jordan P. Metcalf; Catherine L. Hough; William B. Messer; Bali Pulendran; Kari C. Nadeau; Mark M. Davis; Ana Fernandez-Sesma; Viviana Simon; Monica Kraft; Christian Bime; Carolyn S. Calfee; David J. Erle; Joanna Schaenmann; Al Ozonoff; Bjoern Peters; Steven H. Kleinstein; Alison D. Augustine; Joann Diray-Arce; Patrice M. Becker; Nadine Rouphael; IMPACC Network; Jason D. Goldman; Daniel R. Calabrese; James R. Heath; James A. Wells; Elaine F. Reed; Lewis L. Lanier; Harry Pickering; Oscar A. Aguilar